Cost-effectiveness of Rituximab versus Calcineurin inhibitors for refractory Myasthenia Gravis
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1737
https://www.valueinhealthjournal.com/article/S1098-3015(15)01794-5/fulltext
Title :
Cost-effectiveness of Rituximab versus Calcineurin inhibitors for refractory Myasthenia Gravis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01794-5&doi=10.1016/j.jval.2015.03.1737
First page :
A298
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
1216